«Obesity Hypoventilation Syndrome

Below is an extended Obesity Hypoventilation Syndrome patents listing. Click here to return to the Obesity Hypoventilation Syndrome main in depth entry.

Patents :
US Patent No.	Title
5278190	Method for improving the quality of sleep and treating sleep disorders
6029664	Breathing gas delivery method and apparatus
6305374	Breathing gas delivery method and apparatus
6331536	Pharmacological treatment for sleep apnea
6427689	Sleep apnea treatment apparatus
6484719	Method for providing ventilatory assistance in a spontaneously breathing subject
6532957	Assisted ventilation to match patient respiratory need
6539940	Breathing gas delivery method and apparatus
6555564	Neuropharmacological treatments of sleep-related breathing disorders
6575163	Method for calculating the instantaneous inspired volume of a subject during ventilatory assistance
6629527	Sleep apnea treatment apparatus
5970975	Sleep apnea treatment apparatus
5938626	Apparatus for lowering intra-abdominal pressure
5313937	Leak compensation method and apparatus for a breathing system
5433193	Breathing gas delivery method and apparatus
5492113	Sleep apnea treatment apparatus having multiple ramp cycles
5551418	Sleep apnea treatment apparatus with reset circuitry
5632269	Breathing gas delivery method and apparatus
5803065	Breathing gas delivery method and apparatus
5823187	Sleep apnea treatment apparatus with a therapy delay circuit arrangement
5893368	Method for lowering abdominal pressure
5901704	Sleep apnea treatment apparatus with minimum leakage assurance circuit
5904141	Sleep apnea treatment apparatus with reset feature
6644312	Determining suitable ventilator settings for patients with alveolar hypoventilation during sleep
6688307	Methods and apparatus for determining instantaneous elastic recoil and assistance pressure during ventilatory support
6727242	Pharmacological treatment for sleep apnea
7160898	Pharmacological treatment for sleep apnea
7271266	Substituted 2,3-diphenyl pyridines
7276520	Bicyclic piperidine derivatives as melanocortin-4 receptor agonists
7294512	Solution for calibrating a chemical analyzer for alcohol, carbonate and ammonia assays
7329673	Acylated spiropiperidine derivatives as melanocortin-4 receptor agonists
7348456	Substituted amides
7363076	Treatment of conditions through modulation of the autonomic nervous system
7390835	Aralkyl amines as cannabinoid receptor modulators
7414057	Piperazine urea derivatives as melanocortin-4 receptor agonists
7419990	Piperidine derivatives as melanocortin-4 receptor agonists
7160886	Acylated piperazine derivatives as melanocortin-4 receptor agonists
7137389	Method and apparatus for determining instantaneous inspired volume of a subject during ventilatory assistance
6810876	Assisted ventilation to match patient respiratory need
6845773	Determining suitable ventilator settings for patients with alveolar hypoventilation during sleep
6948497	Breathing gas delivery method and apparatus
6972295	Substituted amides
6974814	Neuropharmacological treatment of sleep-related breathing disorders
7013892	Sleep apnea treatment apparatus
7081095	Centralized hospital monitoring system for automatically detecting upper airway instability and for preventing and aborting adverse drug reactions
7089937	Determining suitable ventilator settings for patients with alveolar hypoventilation during sleep
7091216	Substituted furo[2,3-b]pyridine derivatives
7100607	Breathing gas delivery method and apparatus
7423067	Diphenyl cyclopentyl amides as cannabinoid-1 receptor inverse agonists

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.